Who is sponsoring NCT05416151?

NCT05416151 is sponsored by Danone Global Research & Innovation Center.

What drugs are being tested in NCT05416151?

Interventions in NCT05416151: Freeze-dried biotic, Maltodextrin.

What condition does NCT05416151 study?

NCT05416151 studies Gastro-intestinal Symptoms in Healthy Subjects.

Is NCT05416151 still recruiting?

NCT05416151 is currently completed. Last updated 9 August 2024.

Last reviewed 2024-08-09 · How we verify

NCT05416151

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of B.Lactis Consumption on Gastro-Intestinal (GI) Symptoms in Healthy Women Reporting Minor GI Symptoms

Completed NA Last updated 9 August 2024

What this trial tests

NA trial testing Freeze-dried biotic in Gastro-intestinal Symptoms in Healthy Subjects in 486 participants. Completed in 18 April 2024.

Timeline

24 May 2022

Primary endpoint
15 December 2023

18 April 2024

Quick facts

Lead sponsor	Danone Global Research & Innovation Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	supportive care
Enrollment	486
Start date	24 May 2022
Primary completion	15 December 2023
Estimated completion	18 April 2024
Sites	1 location across France

Drugs / interventions tested

Freeze-dried biotic
Maltodextrin (MALTODEXTRIN) — full drug profile →

Conditions studied

Gastro-intestinal Symptoms in Healthy Subjects — all drugs for Gastro-intestinal Symptoms in Healthy Subjects →

Sponsor

Danone Global Research & Innovation Center — full company profile →

Who can join

Adults 18 to 60, female only, with Gastro-intestinal Symptoms in Healthy Subjects. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess the effect of a 28-day B.lactis consumption twice daily on Gastro-Intestinal (GI) symptoms in healthy women reporting minor GI symptoms.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Danone Global Research & Innovation Center trials

Trials by the same sponsor.

NCT06836752 — Effects of Yoghurt Consumption on Glucose Metabolism in Prediabetic Subjects · NA · terminated
NCT06988514 — Stool Collection for Model · NA · completed
NCT06768229 — Survival Plant-Based · NA · completed
NCT04780763 — Effect of 4-week Oral Administration of a Fermented Dairy Product Containing Lactobacillus Rhamnosus CNCM I-3690, on Sub · NA · completed
NCT04301973 — Stools and Life Habits Collection in Heathy Volunteers/Subjects - to Provide Material for in Vitro Model Development · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05416151 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Danone Global Research & Innovation Center
Last refreshed: 9 August 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05416151.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing